Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Réglementation et droit · 07/12/19951 min de lecture
Determination of Regulatory Review Period for Purposes of Patent Extension; ULTANESUPTM
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) has determined the regulatory review period for ULTANE TM and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of an application to the Commissioner of Patents and Trademarks, Department of Commerce, for the extension of a patent which claims that human drug product.
Langue originale de la source: Federal Register — All DocumentsOuvrir le communiqué original →